Tenet Healthcare Corporation ($THC) Stock Forecast: Up 5.1% Today

What is Tenet Healthcare Corporation?

Tenet Healthcare (THC) operates in the healthcare services sector, specializing in high-acuity services and operational efficiencies. The company recently announced robust financial results for Q1 2026, surpassing EPS estimates and reiterating its full-year guidance.

Why is Tenet Healthcare Corporation going up?

THC stock is up 5.1% on May 6, 2026 19:12

• Following the strong Q1 2026 earnings announcement, THC's stock experienced a positive uptick in trading.
• Demonstrating impressive financial performance, the company exceeded EPS projections, highlighting operational strength.
• Despite hurdles such as volume pressures, Tenet Healthcare's emphasis on strategic cost management and outpatient services has been instrumental in driving favorable outcomes.
• Market sentiment remained largely optimistic in response to the company's strong earnings and future prospects, despite varied analyst price target adjustments.

THC Price Chart

THC Technical Analysis

THC News

Earnings call transcript: Tenet Healthcare beats Q1 2026 EPS expectations

Tenet Healthcare (THC) reported strong Q1 2026 results, significantly surpassing EPS expectations with $4.82 against a forecast of $4.16. Despite a slight revenue miss at $5.37 billion, the company achieved a robust adjusted EBITDA margin of 21.6% and generated $978 million in free cash flow. The positive earnings surprise led to a favorable market reaction, with the stock price increasing post-announcement, and the company reaffirmed its full-year 2026 guidance, emphasizing its focus on high-acuity services and operational efficiencies.

https://www.investing.com/news/transcripts/earnings-call-transcript-tenet-healthcare-beats-q1-2026-eps-expectations-93CH-4657091

Tenet Healthcare Shines In Q1 2026 Earnings Call

Tenet Healthcare reported strong Q1 2026 results with $5.4 billion in net operating revenues, $1.162 billion in adjusted EBITDA, and robust free cash flow, indicating solid financial health. The company emphasized its operational momentum and disciplined capital allocation, with USPI continuing to be a strong growth driver. Despite facing headwinds from exchange enrollment, payer mix, and lower respiratory volumes, Tenet reaffirmed its full-year guidance, projecting approximately 10% normalized adjusted EBITDA growth.

https://www.theglobeandmail.com/investing/markets/stocks/THC/pressreleases/1658775/tenet-healthcare-shines-in-q1-2026-earnings-call/

Cost management, outpatient unit helped Tenet weather volume headwinds in Q1

Tenet Healthcare managed to navigate first-quarter volume pressures, unlike some of its peers, through effective cost management and a strategic focus on high-acuity service lines. Despite declines in acute care volumes due to a severe respiratory season and winter storms, Tenet posted stronger-than-expected earnings, buoyed by the strong performance of its ambulatory surgical unit, United Surgical Partners International. The company also reaffirmed its financial guidance for 2026, expecting revenues between $21.5 billion and $22.3 billion.

https://www.healthcaredive.com/news/outpatient-unit-expense-management-helped-tenet-volumes-headwinds-q1-2026/819045/

RBC Cuts Price Target on Tenet Healthcare to $236 From $277, Keeps Outperform Rating

RBC has revised its price target for Tenet Healthcare (THC) shares down to $236 from $277, while maintaining an "Outperform" rating on the stock. This adjustment comes despite several other recent analyst reports showing varied price target changes and the company reporting increased Q1 adjusted earnings and revenue, with raised 2026 EPS guidance. The article also notes Morgan Stanley trimmed its price target on Tenet Healthcare to $254 from $260, but kept an "Overweight" rating.

https://www.marketscreener.com/news/rbc-cuts-price-target-on-tenet-healthcare-to-236-from-277-keeps-outperform-rating-ce7f58d9dc89f72d

Tenet Healthcare Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:THC) 2026-05-01

Tenet Healthcare Corporation (THC) has released its Q1 2026 earnings call presentation. The company reported an EPS of $4.82, beating estimates by $0.65, and revenue of $5.37 billion, which missed estimates by $27.83 million despite a 2.78% year-over-year increase. The provided slide deck accompanies the earnings call.

https://seekingalpha.com/article/4897385-tenet-healthcare-corporation-2026-q1-results-earnings-call-presentation

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.1% Today

Solana ($SOL) Crypto Forecast: Down 5.6% Today

Advance Auto Parts Inc W/I ($AAP) Stock Forecast: Down 5.1% Today

NRG Energy Inc. ($NRG) Stock Forecast: Down 5.0% Today

Ubiquiti ($UI) Stock Forecast: Down 5.2% Today

Franco-Nevada Corp. ($FNV) Stock Forecast: Down 5.2% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Up 11.1% Today

Ford Motor Company ($F) Stock Forecast: Down 7.1% Today

ServiceNow Inc. ($NOW) Stock Forecast: Up 5.0% Today

Kornit Digital Ltd. ($KRNT) Stock Forecast: Down 5.4% Today

Tenet Healthcare Corporation Price History

31.02.2026 - THC Stock was down 4.2%

• A decision to disaggregate holdings and report 0% ownership of Tenet Healthcare (THC) by a major institutional investor may have signaled a lack of confidence in the company's future performance, leading to a bearish sentiment among investors.
• An internal realignment within the mentioned institutional investor, resulting in subsidiaries reporting ownership separately, could have created uncertainty and potentially triggered selling pressure on THC shares.
• Investors may interpret this institutional investor's move as a strategic shift away from healthcare stocks like THC, contributing to the bearish movement in the company's stock price today.

18.02.2026 - THC Stock was down 5.3%

• THC shares declined by 3.7% today, possibly due to profit-taking following upbeat financial results and a positive future outlook.
• The bearish movement may be linked to investors capitalizing on their previous gains from THC's recent stock performance.
• Insider selling activity and absence of new negative information hint that the decline may be driven more by market dynamics and valuation adjustments rather than intrinsic company issues.
• Despite the recent dip, analysts' "Moderate Buy" rating and the company's robust earnings performance indicate growth potential for THC in the future.

01.04.2026 - THC Stock was up 5.1%

• Tenet Healthcare's Q1 earnings surpassed expectations, showing resilience despite challenges like a soft flu season, winter storms, and a cybersecurity event.
• Growth in joint replacements and ASC acquisitions drove strong performance in the company's USPI segment, contributing to the bullish movement in its stock.
• Strategic investments in technology and AI, as well as reaffirmed guidance for 2026, have boosted investor confidence in Tenet Healthcare's long-term growth prospects, despite slight concerns about overvaluation.
• Vanguard's significant stake in the company underlines investor faith in its future potential and strategic direction, bolstering positive sentiment around the stock.

01.04.2026 - THC Stock was up 7.2%

• Investors remained positive even after RBC's price target cut on THC, as the company's Q1 earnings surpassed expectations, demonstrating resilience and growth prospects.
• Challenges like a mild flu season and an unfavorable mix of payers affected sales, but THC's strategic investments in its USPI segment and efficient operations boosted investor sentiment.
• CEO Saum Sutaria's focus on managing volume disruptions with traditional methods proved successful, underscoring THC's capability to maintain healthy margins through effective cost control.
• Despite obstacles, THC's decision to maintain its full-year guidance reflects a sound long-term strategy and confidence in its diversified asset portfolio.

30.03.2026 - THC Stock was down 5.5%

• THC stock witnessed a notable downward trend, decreasing by 5.8% to conclude at $177.38.
• The drop was not linked to any company-specific developments but was part of a broader sector-wide decline impacting hospital operators like HCA and Universal Health Services.
• Investors might be reconsidering the healthcare sector in light of macroeconomic factors such as reimbursement trends or cost pressures, leading to a synchronized industry downturn.
• Despite recent positive financial performance and growth projections outlined in recent assessments, the overvaluation of THC stock and broader industry worries likely played a role in the bearish market movement.

17.02.2026 - THC Stock was down 5.4%

• The bearish movement in Tenet Healthcare's stock today could be due to profit-taking by investors following a recent rally post-upbeat full-year 2025 results and a positive 2026 outlook.
• A notable insider selling activity, involving various institutional investors reducing their stakes in the company, including Ameriprise Financial Inc., Iron Triangle Partners LP, Farallon Capital Management LLC, and Brevan Howard Capital Management LP, may have also contributed to the stock's downward trend.
• Despite the insider selling, analysts are holding a "Moderate Buy" rating on $THC, with an average price target of $250.56, reflecting optimism in the company's long-term potential amid temporary market fluctuations.
• The absence of any recent negative developments suggests that the decline in Tenet Healthcare's stock price today is likely driven by trading patterns and valuation adjustments rather than fundamental issues within the company itself.

14.03.2026 - THC Stock was up 5.3%

• THC stocks fell by 3.28% despite surpassing Q4 2025 earnings expectations, likely due to cautious 2026 guidance predicting a 20% decline in exchange marketplace enrollment.
• The substantial trading volume indicates a significant debate between bullish investors emphasizing operational strength and M&A strategy, and bearish investors worried about future regulatory and macroeconomic obstacles.
• Despite a 3.3% decrease to $195.24, suggesting overvaluation, there appears to be a gap between market price and intrinsic value, with insider selling contributing to investor hesitancy.
• The retirement announcement of Paola Arbour, Tenet Healthcare's EVP & CIO, though not directly linked to the current market movement, may hint at potential executive changes that investors are monitoring closely.

13.02.2026 - THC Stock was down 5.0%

• THC's stock price experienced a bearish movement today due to significant insider selling activity by the EVP at Tenet Healthcare, Thomas W. Arnst, who sold 8,000 shares worth $1.91 million, reducing his position by 99.85%.
• The market's negative sentiment towards THC can be attributed to its high debt-to-equity ratio of 3.12, the insider selling trend with no recorded insider buys in the past year, and concerns about potential overvaluation.
• Although THC recently won a lawsuit regarding hospital safety ratings, the focus on insider selling and valuation metrics likely overshadowed this positive news, contributing to the bearish market movement.

24.03.2026 - THC Stock was down 8.4%

• The bearish movement in THC stock could be attributed to underperforming the S&P 500, declining by 2.74% in the latest trading session.
• Investors might be reacting to the upcoming earnings report on April 30, 2026, with analysts expecting an EPS of $4.19 and revenue of $5.39 billion, which could be causing uncertainty and selling pressure.
• The emphasis on mobile-first delivery of financial news by Google's 2026 Discover Core Update could be impacting investor sentiment, with tailored insights on THC's performance and strategic shifts towards ambulatory care and revenue management potentially influencing trading decisions.
• The market's reaction to the mobile-first approach could be signaling a shift in investor behavior towards more proactive and concise information delivery, impacting stock movements like THC's bearish trend today.

12.01.2026 - THC Stock was up 13.0%

• Tenet Healthcare's stock (THC) experienced a strong bullish movement recently.
• The positive trend is linked to the company's successful revitalization efforts, which include divesting underperforming assets and emphasizing high-margin ambulatory surgery services.
• Strong Q4 2025 results have shown net operating revenues of $5.527 billion and adjusted diluted EPS increasing by 36.6% to $4.70, boosting investor confidence.
• With an encouraging 2026 outlook projecting net operating revenues between $21.5 billion and $22.3 billion, investors have shown increased optimism, leading to the stock reaching an all-time high.

24.02.2026 - THC Stock was down 5.2%

• The bearish movement in THC's stock price could be attributed to the overall decline in the healthcare sector, as evidenced by the recent 10.1% drop in the stock over the last month.
• Despite beating earnings expectations and holding a "Moderate Buy" consensus rating from analysts, insider selling and the reduction in stake by institutional investors like Cambria Investment Management L.P. might have contributed to the negative sentiment surrounding THC.
• The market's reaction to THC's strong quarterly earnings report could indicate that investors are focusing more on the recent insider selling and institutional adjustments rather than the company's financial performance.
• The combination of these factors, along with the broader market and sector drops, likely led to the bearish movement in THC's stock price despite its positive earnings report.

06.04.2026 - THC Stock was up 5.1%

• Following the strong Q1 2026 earnings announcement, THC's stock experienced a positive uptick in trading.
• Demonstrating impressive financial performance, the company exceeded EPS projections, highlighting operational strength.
• Despite hurdles such as volume pressures, Tenet Healthcare's emphasis on strategic cost management and outpatient services has been instrumental in driving favorable outcomes.
• Market sentiment remained largely optimistic in response to the company's strong earnings and future prospects, despite varied analyst price target adjustments.